AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin.
Rosen DB; Harrington KH; Cordeiro JA; Leung LY; Putta S; Lacayo N; Laszlo GS; Gudgeon CJ; Hogge DE; Hawtin RE; Cesano A; Walter RB; Plos One, 2013, vol. 8, issue 1, p e53518, ISSN 19326203. ISBN 19326203.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef